FOXO4-DRI 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of FOXO4-DRI supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025009

Key analytical results include:

• Assay Content: 10.57 mg
• Identification – Retention Time: 0.997
• Identification – Spectrum: 998
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

FOXO4-DRI is a synthetic research peptide frequently studied in laboratory environments focused on cellular senescence signalling pathways and protein interaction networks.

The compound belongs to a class of peptides designed to interact with regulatory proteins involved in cellular stress responses and intracellular signalling mechanisms.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide sequence and stable analytical profile, FOXO4-DRI has become a reference compound in experimental cellular ageing and protein interaction research models.

Compound Overview

FOXO4-DRI is a synthetic peptide derived from sequences associated with the forkhead box O4 (FOXO4) transcription factor.

Within cellular biology research, FOXO proteins are known to participate in signalling networks that regulate gene expression related to cellular stress responses, metabolic activity and programmed cellular processes.

The FOXO4-DRI peptide has been studied in laboratory settings exploring its interaction with intracellular regulatory proteins and signalling complexes associated with senescent cellular states.

These studies allow researchers to investigate how peptide-mediated protein interactions influence regulatory pathways inside the cell.

Historical Background and Scientific Context

Scientific research into cellular ageing and senescence accelerated significantly during the early twenty-first century as molecular biology techniques improved.

During this period researchers began identifying signalling pathways that regulate cellular ageing processes and the behaviour of senescent cells.

Proteins belonging to the FOXO family were identified as key transcription factors involved in cellular stress regulation and longevity-associated signalling pathways.

Experimental peptides such as FOXO4-DRI were subsequently developed to study protein–protein interactions within these regulatory networks.

Mechanistic Focus in Research

Within experimental laboratory environments, FOXO4-DRI is often studied in relation to cellular signalling pathways associated with senescence and protein interaction dynamics.

Research investigations commonly explore the compound in experimental models examining:

• FOXO transcription factor signalling pathways
• Protein–protein interaction dynamics
• Cellular senescence signalling networks
• Intracellular regulatory pathway modelling
• Molecular protein interaction research
• Comparative peptide interaction studies
• Cellular stress response signalling mechanisms

These experimental models allow scientists to investigate molecular mechanisms influencing cellular regulatory processes and intracellular signalling behaviour.

Research Applications

In controlled research environments, FOXO4-DRI may be utilised in experimental models designed to explore cellular regulatory pathways and protein interaction systems.

Examples of research applications include:

• Cellular signalling pathway investigation
• Protein interaction research
• Senescence pathway modelling
• Molecular regulatory network analysis
• Comparative peptide interaction studies
• Biochemical signalling pathway research
• Controlled in vitro cellular regulation experiments

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• Endotoxin below 0.001 EU per mg
• No detectable heavy metals or microbial contamination
• Batch GF082025009 – Published October 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.